Serotonin 5-HT2C Receptors as a Target for the Treatment of Depressive and Anxious States: Focus on Novel Therapeutic Strategies

Requirement of Hippocampal Neurogenesis for the Behavioral Effects of Antidepressants

2003 • 4,175 citations

A review of central 5-HT receptors and their function

1999 • 3,121 citations

Descending control of pain

2002 • 2,885 citations

Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project

2004 • 1,794 citations

Brain-Derived Neurotrophic Factor Produces Antidepressant Effects in Behavioral Models of Depression

2002 • 1,627 citations

The Economic Burden of Depression in the United States

2003 • 1,306 citations

Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors

1995 • 1,264 citations

Cognitive deficits in depression: Possible implications for functional neuropathology

2001 • 1,146 citations

Discovering Endophenotypes for Major Depression

2004 • 1,095 citations

Role of 5-HT in stress, anxiety, and depression

1996 • 972 citations

Neuroanatomical Hypothesis of Panic Disorder, Revised

2000 • 969 citations

The neurobiology and control of anxious states

2003 • 957 citations

Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability

2000 • 937 citations

Adult brain neurogenesis and psychiatry: a novel theory of depression

2000 • 936 citations

Pharmacological profile of antidepressants and related compounds at human monoamine transporters

1997 • 906 citations

Cell Proliferation in Adult Hippocampus is Decreased by Inescapable Stress: Reversal by Fluoxetine Treatment

2003 • 796 citations

Neuroimaging studies of priming

2003 • 761 citations

Serotonin receptors : their key role in drugs to treat schizophrenia

2003 • 759 citations

The European Study of the Epidemiology of Mental Disorders (ESEMeD) project: an epidemiological basis for informing mental health policies in Europe

2004 • 715 citations

Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

2000 • 698 citations

Bupropion: a review of its mechanism of antidepressant activity.

1995 • 693 citations

From magic bullets to designed multiple ligands

2004 • 689 citations

Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system.

2001 • 678 citations

Unraveling the attentional functions of cortical cholinergic inputs: interactions between signal-driven and cognitive modulation of signal detection

2004 • 662 citations

Effects of SSRIs on Sexual Function

1999 • 652 citations

Agonist-receptor efficacy II: agonist trafficking of receptor signals

1995 • 637 citations

Disability and quality of life impact of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project

2004 • 574 citations

Functional Correlates of Serotonin 5-HT₁Recognition Sites

1988 • 564 citations

SB 242084, a Selective and Brain Penetrant 5-HT 2C Receptor Antagonist

1997 • 519 citations

Neurocognitive impairment in drug-free patients with major depressive disorder

2003 • 516 citations

Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression

2002 • 513 citations

Serotonin-Induced Increases in Adult Cell Proliferation and Neurogenesis are Mediated Through Different and Common 5-HT Receptor Subtypes in the Dentate Gyrus and the Subventricular Zone

2003 • 506 citations

Effector Pathway-Dependent Relative Efficacy at Serotonin Type 2A and 2C Receptors: Evidence for Agonist-Directed Trafficking of Receptor Stimulus

1998 • 502 citations

The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine_2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways

2003 • 499 citations

Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for Difficult-to-Treat depression

2003 • 494 citations

Molecular Neurobiology for Practicing Psychiatrists, Part 5: How a Leucine Zipper Can Turn On Genes: Immediate-Early Genes Activate Late-Gene Expression in the Brain.

2000 • 492 citations

A meta–analysis of functional neuroimaging in obsessive–compulsive disorder

2004 • 491 citations

The Neural Substrates of Affective Processing in Depressed Patients Treated With Venlafaxine

2002 • 489 citations

5-HT1A receptor agonists: recent developments and controversial issues

1995 • 463 citations

Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.

1999 • 427 citations

Dopamine and serotonin: influences on male sexual behavior

2004 • 421 citations

Don't worry ‘B’ happy!: a role for GABAB receptors in anxiety and depression

2004 • 405 citations

Altered Editing of Serotonin 2C Receptor Pre-mRNA in the Prefrontal Cortex of Depressed Suicide Victims

2002 • 370 citations

Immunohistochemical localisation of the 5-HT2C receptor protein in the rat CNS

2000 • 367 citations

Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT2C antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study

2002 • 363 citations

RNA Editing of the Human Serotonin 5-Hydroxytryptamine 2C Receptor Silences Constitutive Activity

1999 • 353 citations

Nicotinic Receptors in the Brain Links between Molecular Biology and Behavior

2000 • 352 citations

Functional characterization of agonists at recombinant human 5‐HT_2A, 5‐HT_2B and 5‐HT_2C receptors in CHO‐K1 cells

1999 • 347 citations

Serotonin2C receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: A combined dialysis and electrophysiological analysis in the rat

2000 • 333 citations

5-HT2C receptor agonists: pharmacological characteristics and therapeutic potential.

1998 • 324 citations

Neurobiological bases for the relation between sleep and depression

2002 • 320 citations

Regulation of hippocampal synaptic plasticity by cyclic AMP-dependent protein kinases

2003 • 320 citations

Evidence-based pharmacotherapy of obsessive-compulsive disorder

2012 • 317 citations

Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project

2004 • 312 citations

Mechanism of action of antidepressant medications.

1999 • 307 citations

Constitutive Activity of the Serotonin2C Receptor InhibitsIn VivoDopamine Release in the Rat Striatum and Nucleus Accumbens

2004 • 301 citations

Antidepressant effects of inhibitors of cAMP phosphodiesterase (PDE4)

2004 • 299 citations

Psychopharmacology: The fourth generation of progress

1996 • 297 citations

Antidepressant-like behavioral effects mediated by 5-Hydroxytryptamine(2C) receptors.

2000 • 286 citations

Effects of centrally administered anxiolytic compounds in animal models of anxiety

1999 • 284 citations

Effect of Agomelatine in the Chronic Mild Stress Model of Depression in the Rat

2002 • 260 citations

12‐Month comorbidity patterns and associated factors in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project

2004 • 252 citations

RNA Editing of the Human Serotonin 5-HT2C Receptor Alterations in Suicide and Implications for Serotonergic Pharmacotherapy

2001 • 249 citations

Constitutively active 5-hydroxytryptamine2C receptors reveal novel inverse agonist activity of receptor ligands.

1994 • 249 citations

Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635

2001 • 249 citations

The role of monoamines in the actions of established and “novel” antidepressant agents: a critical review

2004 • 248 citations

Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders

2004 • 248 citations

The role of the brain reward system in depression

2001 • 247 citations

A double-blind, placebo-controlled study of antidepressant augementation with mirtazapine

2002 • 244 citations

Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade

2004 • 244 citations

A review of the role of serotonin receptors in psychiatric disorders

2000 • 242 citations

Monoamine depletion in psychiatric and healthy populations: review

2003 • 240 citations

Pattern of expression of the serotonin2C receptor messenger RNA in the basal ganglia of adult rats

1997 • 240 citations

In vitro and in vivo profile of SB 206553, a potent 5‐HT_2C/5‐HT_2B receptor antagonist with anxiolytic‐like properties

1996 • 239 citations

The pharmacology of putative early-onset antidepressant strategies

2003 • 237 citations

Role of 5-HT2C receptors in the control of central dopamine function

2001 • 236 citations

Is There a Delay in the Antidepressant Effect? A Meta-Analysis

2005 • 233 citations

Novel naphthalenic ligands with high affinity for the melatonin receptor

1992 • 233 citations

Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents

2000 • 225 citations

Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study

1999 • 220 citations

Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors.

2004 • 216 citations

Cytokines as a Precipitant of Depressive Illness: Animal and Human Studies

2005 • 215 citations

Neuronal nicotinic acetylcholine receptor subunit knockout mice: physiological and behavioral phenotypes and possible clinical implications

2001 • 214 citations

5-HT2A and 5-HT2C receptors and their atypical regulation properties

2003 • 210 citations

Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-chlorophenylpiperazine given intravenously or orally to healthy volunteers

1989 • 202 citations

Absence of discontinuation symptoms with agomelatine and occurrence of discontinuation symptoms with paroxetine: a randomized, double-blind, placebo-controlled discontinuation study

2004 • 201 citations

Antidepressant medications: a review of the evidence for drug-induced sexual dysfunction

2002 • 200 citations

Neuropsychological and neuroimaging evidence for the involvement of the frontal lobes in depression

1997 • 200 citations

Evidence-based pharmacotherapy of obsessive–compulsive disorder

2005 • 200 citations

Antidepressant-like behavioral effects in 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) receptor mutant mice.

2001 • 199 citations

Altered G Protein‐Coupling Functions of RNA Editing Isoform and Splicing Variant Serotonin_2C Receptors

2000 • 195 citations

Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2C receptor

1996 • 193 citations

Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive–compulsive disorder responses

1998 • 189 citations

Decreased Presynaptic Dopamine Function in the Left Caudate of Depressed Patients With Affective Flattening and Psychomotor Retardation

2001 • 182 citations

Serotonin 5‐HT_2C Receptor RNA Editing Alters Receptor Basal Activity

1999 • 180 citations

Blockage of 5HT_2Cserotonin receptors by fluoxetine (Prozac)

1997 • 178 citations

Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin2C/2B receptor agonists: a combined in vivo electrophysiological and microdialysis study

2000 • 175 citations

Contributions of 5-HT2C receptors to multiple actions of central serotonin systems

2004 • 171 citations

Functional characteristics of heterologously expressed 5-HT receptors

1997 • 169 citations

The pharmacology of weight gain with antipsychotics.

2001 • 167 citations

Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of α₂‐adrenergic and serotonin_2C receptors: a comparison with citalopram

2000 • 167 citations

The Serotonin 5-HT2A and 5-HT2C Receptors Interact with Specific Sets of PDZ Proteins

2004 • 167 citations

Stress-induced vocalisation in adult animals. A valid model of anxiety?

2003 • 160 citations

Modulation of Serotonin 2C Receptor Editing by Sustained Changes in Serotonergic Neurotransmission

2002 • 158 citations

Substance P receptor antagonist and clomipramine prevent stress-induced alterations in cerebral metabolites, cytogenesis in the dentate gyrus and hippocampal volume

2002 • 157 citations

Inactivation of 5-HT2C Receptors Potentiates Consequences of Serotonin Reuptake Blockade

2004 • 156 citations

Serotonin and drug reward: focus on 5-HT2C receptors

2003 • 155 citations

Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression

2002 • 152 citations

Comparison of the phenotype of NK1R−/− mice with pharmacological blockade of the substance P (NK 1 ) receptor in assays for antidepressant and anxiolytic drugs

2001 • 151 citations

Role of serotonin2C receptors in the control of brain dopaminergic function

2002 • 151 citations

Antidepressant-like behavioral effects of serotonin receptor agonists

1994 • 149 citations

The Vogel conflict test: procedural aspects, γ-aminobutyric acid, glutamate and monoamines

2003 • 146 citations

Differential Actions of Serotonin, Mediated by 5-HT_1Band 5-HT_2CReceptors, on GABA-Mediated Synaptic Input to Rat Substantia Nigra Pars Reticulata NeuronsIn Vitro

1996 • 143 citations

Nefazodone

1997 • 141 citations

Pindolol and Mianserin Augment the Antidepressant Activity of Fluoxetine in Hospitalized Major Depressed Patients, Including Those With Treatment Resistance

1999 • 140 citations

Influence of the 5-HT2C receptor antagonist, SB-242084, in tests of anxiety

2002 • 139 citations

RNA‐editing of the 5‐HT_2C receptor alters agonist‐receptor‐effector coupling specificity

2001 • 139 citations

S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.

2001 • 136 citations

Increased 5-HT2C receptor responsiveness occurs on rearing rats in social isolation

1996 • 136 citations

A Comparison of Melatonin Secretion in Depressed Patients and Normal Subjects

1988 • 135 citations

THE PINEAL GLAND AND MELATONIN: Molecular and Pharmacologic Regulation

1999 • 135 citations

Mirtazapine Augmentation in the Treatment of Refractory Depression

1999 • 134 citations

RNA editing of serotonin 2C receptor in human postmortem brains of major mental disorders

2003 • 131 citations

Strategies for producing faster acting antidepressants

2005 • 129 citations

Successful use of S20098 and melatonin in an animal model of delayed sleep-phase syndrome (DSPS)

1993 • 128 citations

Mirtazapine

1996 • 125 citations

Mirtazapine Substitution in SSRI-Induced Sexual Dysfunction

2000 • 125 citations

Neuroendocrine Aspects of Primary Endogenous Depression

1992 • 124 citations

A Comparative Study of the Effects of Selective and Non-Selective 5-HT2 Receptor Subtype Antagonists in Rat and Mouse Models of Anxiety

1997 • 123 citations

Pharmacology of Flibanserin

2002 • 122 citations

5-HT2C receptors mediate penile erections in rats: actions of novel and selective agonists and antagonists

1997 • 122 citations

Conditioned ultrasonic distress vocalizations in adult male rats as a behavioural paradigm for screening anti-panic drugs

1995 • 121 citations

5HT2C receptor agonists exhibit antidepressant-like properties in the anhedonia model of depression in rats

1996 • 120 citations

Antidepressants and Ejaculation: A Double-Blind, Randomized, Placebo-Controlled, Fixed-Dose Study With Paroxetine, Sertraline, and Nefazodone

2001 • 117 citations

Perturbed dentate gyrus function in serotonin 5-HT _2C receptor mutant mice

1998 • 116 citations

Dose dependent effects of S-20098, a melatonin agonist, on direction of re-entrainment of rat circadian activity rhythms

1995 • 111 citations

Melatonin as an anxiolytic in rats: time dependence and interaction with the central GABAergic system

1993 • 111 citations

Separation of anxiety and depressive disorders: blind alley in psychopharmacology and classification of disease

2003 • 108 citations

Melatonin analogues as agonists and antagonists in the circadian system and other brain areas

1996 • 108 citations

The Use of Trazodone as a Hypnotic

2004 • 106 citations

Differential Activation of Gq/11 and Gi₃Proteins at 5-Hydroxytryptamine_2CReceptors Revealed by Antibody Capture Assays: Influence of Receptor Reserve and Relationship to Agonist-Directed Trafficking

2002 • 106 citations

Effect of chronic administration of selective 5-hydroxytryptamine and noradrenaline uptake inhibitors on a putative index of 5-HT2C/2B receptor function

1994 • 106 citations

Involvement of 5-HT1A and 5-HT2 receptors of the dorsal periaqueductal gray in the regulation of the defensive behaviors generated by the elevated T-maze

2004 • 105 citations

Stress and central Urocortin increase anxiety-like behavior in the social interaction test via the CRF1 receptor

2005 • 104 citations

GPCR-interacting proteins (GIPs): nature and functions

2004 • 100 citations

Novel Agonists of 5HT_2C Receptors. Synthesis and Biological Evaluation of Substituted 2-(Indol-1-yl)-1-methylethylamines and 2-(Indeno[1,2-b]pyrrol-1-yl)-1-methylethylamines. Improved Therapeutics for Obsessive Compulsive Disorder

1997 • 99 citations

Activation of 5-HT 2B Receptors in the Medial Amygdala causes Anxiolysis in the Social Interaction Test in the Rat

1997 • 99 citations

SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety

2001 • 99 citations

Serotonin 5-HT2c agonists mimic the effect of light pulses on circadian rhythms

1998 • 99 citations

Novel actions of inverse agonists on 5-HT2C receptor systems.

1999 • 98 citations

WAY-163909 [(7bR, 10aR)-1,2,3,4,8,9,10,10a-Octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole], a Novel 5-Hydroxytryptamine 2C Receptor-Selective Agonist with Anorectic Activity

2005 • 97 citations

Citalopram reduces social interaction in rats by activation of serotonin (5-HT)2C receptors

2000 • 97 citations

Anxiolytic Properties of the Selective, Non-peptidergic CRF1 Antagonists, CP154,526 and DMP695 A Comparison to Other Classes of Anxiolytic Agent

2001 • 95 citations

G protein signaling and the molecular basis of antidepressant action

2003 • 93 citations

Alpha₂‐adrenoceptor mediated co‐release of dopamine and noradrenaline from noradrenergic neurons in the cerebral cortex

2004 • 91 citations

5-Hydroxytryptamine2C receptors on spinal neurons controlling penile erection in the rat

1999 • 91 citations

Norepinephrine involvement in antidepressant action.

2000 • 88 citations

Altered RNA editing of serotonin 5-HT2C receptor induced by interferon: implications for depression associated with cytokine therapy

2004 • 88 citations

Evidence that central 5‐HT_2A and 5‐HT_2B/C receptors regulate 5‐HT cell firing in the dorsal raphe nucleus of the anaesthetised rat

2003 • 87 citations

Comparison of the effects of acute fluvoxamine and desipramine administration on melatonin and cortisol production in humans.

1994 • 86 citations

Anti-depressant action of melatonin in chronic forced swimming-induced behavioral despair in mice, role of peripheral benzodiazepine receptor modulation

2000 • 86 citations

Biochemical and Biophysical Characterization of Serotonin 5-HT_2CReceptor Homodimers on the Plasma Membrane of Living Cells

2004 • 86 citations

Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated

1998 • 86 citations

Interactions between 5-hydroxytryptamine receptor subtypes: Is a disturbed receptor balance contributing to the symptomatology of depression in humans?

1995 • 85 citations

Increased neurogenesis and brain‐derived neurotrophic factor in neurokinin‐1 receptor gene knockout mice

2003 • 84 citations

Pharmacological characterisation of human 5-HT2 receptor subtypes

2001 • 83 citations

Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex

2004 • 83 citations

Characterization of phospholipase C activity at h5-HT 2C compared with h5-HT 2B receptors: influence of novel ligands upon membrane-bound levels of [ 3 H]phosphatidylinositols

2002 • 82 citations

Sexual dysfunction associated with antidepressant drugs

2004 • 81 citations

Distribution of the 5-hydroxytryptamine2C receptor protein in adult rat brain and spinal cord determined using a receptor-directed antibody: Effect of 5,7-dihydroxytryptamine

1997 • 81 citations

Developing novel treatments for mood disorders: accelerating discovery

2002 • 81 citations

Clinical efficacy of mirtazapine: a review of meta-analyses of pooled data

1995 • 78 citations

Use of melatonin for sleep and circadian rhythm disorders

1998 • 78 citations

Evidence for accelerated desensitisation of 5-HT2C receptors following combined treatment with fluoxetine and the 5-HT1A receptor antagonist, WAY 100,635, in the rat

2000 • 74 citations

Moderate dieting causes 5-HT _2C receptor supersensitivity

1996 • 72 citations

Antihistaminic drugs increase feeding, while histidine suppresses feeding in rats

1988 • 71 citations

Increased basal phosphorylation of the constitutively active serotonin 2C receptor accompanies agonist-mediated desensitization.

1995 • 70 citations

Serotonergic antagonists differentially inhibit spontaneous activity and decrease ligand binding capacity of the rat 5-hydroxytryptamine type 2C receptor in Sf9 cells.

1995 • 69 citations

Antidepressants and Ejaculation: A Double-Blind, Randomized, Fixed-Dose Study With Mirtazapine and Paroxetine

2003 • 67 citations

Effects of repeated mild stress and two antidepressant treatments on the behavioral response to 5HT1C receptor activation in rats

1993 • 66 citations

Effects of melatonin receptor ligands on swim test immobility

1998 • 66 citations

Selective blockade of neurokinin (NK)₁ receptors facilitates the activity of adrenergic pathways projecting to frontal cortex and dorsal hippocampus in rats

2001 • 66 citations

Blockade of substance P (neurokinin 1) receptors enhances extracellular serotonin when combined with a selective serotonin reuptake inhibitor: an in vivo microdialysis study in mice

2004 • 66 citations

Entrainment of Rat Circadian Rhythms by the Melatonin Agonist S-20098 Requires Intact Suprachiasmatic Nuclei But Not the Pineal

1998 • 64 citations

Depression, cytokines, and glial function

2005 • 64 citations

Receptor subtype and density determine the coupling repertoire of the 5-ht2 receptor subfamily

1996 • 64 citations

The role of 5ht2c receptors in affective disorders

1998 • 63 citations

Brain 5-HT1C receptors and antidepressants

1994 • 62 citations

Combined effects of diazepam and melatonin in two tests for anxiolytic activity in the mouse

1992 • 62 citations

Ligand Dependency of 5-Hydroxytryptamine 2C Receptor Internalization

2004 • 62 citations

Effects of Trazodone and Fluoxetine in the Treatment of Major Depression

1997 • 58 citations

Agomelatine(S 20098) antagonizes the penile erections induced by the stimulation of 5-HT 2C receptors in Wistar rats

2003 • 57 citations

Melatonin: Therapeutic Use in Sleep Disorders

1997 • 57 citations

Modulation of GABA A Receptor Function by G Protein-coupled 5-HT 2C Receptors

1996 • 57 citations

The 5-HT2C receptor as a target for mood disorders

2004 • 57 citations

Ritanserin, Imipramine, and Placebo in the Treatment of Dysthymic Disorder

1993 • 57 citations

Future Antidepressants

2004 • 56 citations

Agonist-Directed Signaling of Serotonin 5-HT2C Receptors Differences Between Serotonin and Lysergic Acid Diethylamide (LSD)

1999 • 55 citations

Reboxetine, a New Noradrenaline Selective Antidepressant, Is at Least as Effective as Fluoxetine in the Treatment of Depression

2002 • 54 citations

Melatonin agonists modulate 5-HT2A receptor-mediated neurotransmission: behavioral and biochemical studies in the rat.

1995 • 54 citations

m-CPP hypolocomotion is selectively antagonized by compounds with high affinity for 5-HT2C receptors but not 5-HT2A or 5-HT2B receptors

2001 • 53 citations

New approaches to developing antidepressants by enhancing monoaminergic neurotransmission

2003 • 53 citations

Discriminative stimulus effects of m-chlorophenylpiperazine as a model of the role of serotonin receptors in anxiety

2003 • 50 citations

Selecting pharmacotherapy for generalized anxiety disorder.

2004 • 50 citations

Escitalopram in the treatment of social anxiety disorder: Analysis of efficacy for different clinical subgroups and symptom dimensions

2004 • 49 citations

Possible Role(s) of Neurokinins in CNS Development and Neurodegenerative or Other Disorders

1998 • 47 citations

Melatonin modulates the sensitivity of 5-hydroxytryptamine-2 receptor-mediated sleep—wakefulness regulation in the rat

1989 • 46 citations

The effects of administration of mCPP on psychological, cognitive, cardiovascular, hormonal and MHPG measurements in human volunteers

1994 • 46 citations

Citalopram‐induced hypophagia is enhanced by blockade of 5‐HT_1A receptors: role of 5‐HT_2C receptors

1998 • 46 citations

Timing is everything: does the robust upregulation of noradrenergically regulated plasticity genes underlie the rapid antidepressant effects of sleep deprivation?

2002 • 46 citations

Treating depression to remission.

2003 • 45 citations

Positive Allosteric Modulator of the Human 5-HT_2CReceptor

2003 • 44 citations

Serotonin, excitatory amino acids and the photic control of melatonin rhythms and SCN c-FOS in the rat

2001 • 44 citations

Anxiolytic-like properties of melatonin receptor agonists in mice: involvement of mt1 and/or MT2 receptors in the regulation of emotional responsiveness

2000 • 43 citations

Psychopharmacology of depression

1994 • 43 citations

Beyond the Treatment of Epilepsy: New Applications of Vagus Nerve Stimulation in Psychiatry

2003 • 42 citations

SSRI treatment decreases prolactin and hyperthermic responses to mCPP

1997 • 42 citations

Involvement of 5-HT2C receptors in the anti-immobility effects of antidepressants in the forced swimming test in mice

2001 • 42 citations

Acute low doses of melatonin restore full sexual activity in impotent male rats

2000 • 38 citations

Noradrenergic Function and Clinical Outcome in Antidepressant Pharmacotherapy

2001 • 38 citations

5-HT2 receptors differentially modulate dopamine-mediated auto-inhibition in A9 and A10 midbrain areas of the rat

2003 • 37 citations

Effect of SB-243213, a selective 5-HT2C receptor antagonist, on the rat sleep profile

2002 • 37 citations

Efficacy and tolerability of duloxetine, a novel dual reuptake inhibitor, in the treatment of major depressive disorder.

2003 • 36 citations

Discriminative stimulus properties of antidepressant agents: a review.

2003 • 35 citations

Diurnal profile of melatonin concentrations in patients with major depression: relationship to the clinical manifestation and antidepressant treatment.

2001 • 34 citations

The selective neurokinin (NK)1 antagonist, GR205,171, stereospecifically enhances mesocortical dopaminergic transmission in the rat: a combined dialysis and electrophysiological study

2002 • 33 citations

Antidepressant Therapy at the Dawn of the Third Millennium

1999 • 32 citations

Molecular and Functional Characterization of Proteins Interacting with the C-Terminal Domains of 5-HT2 Receptors: Emergence of 5-HT2 ?Receptosomes?

2004 • 32 citations

The adverse effects of antidepressants

1997 • 32 citations

Effects of antidepressants on intracellular Ca2+ mobilization in CHO cells transfected with the human 5-HT2C receptors

1996 • 32 citations

Antagonistic Effects of S 22153, a New mt1 and MT2 Receptor Ligand, on the Neophobia-Reducing Properties of Melatonin in BALB/c Mice

1999 • 32 citations

Dopamine and melatonin in the nucleus accumbens may be implicated in the mode of action of antidepressant drugs

1992 • 30 citations

Chronic treatment with clomipramine and mianserin increases the hierarchical position of subdominant rats housed in triads

1992 • 30 citations

Effects of single and repeated electroconvulsive shock on the social and agonistic behaviour of resident rats

2003 • 28 citations

Chromic mianserin or eltoprazine treatment in rats: effects on the elevated plus-maze test and on limbic 5-HT2C receptor levels

1994 • 27 citations

Molecular and Functional Characterization of Proteins Interacting with the C‐Terminal Domains of 5‐HT2 Receptors: Emergence of 5‐HT2 “Receptosomes”

2004 • 27 citations

Treatment strategies for sleep disturbance in patients with depression.

2003 • 26 citations

Agonist-induced GTPγ35S binding mediated by human 5-HT2C receptors expressed in human embryonic kidney 293 cells

1999 • 25 citations

Precision and Comparability of Adverse Event Rates of Newer Antidepressants

1999 • 23 citations

Psychomotor slowing, neuroendocrine responses, and behavioral changes after oral administration of meta-chlorophenylpiperazine in normal volunteers

2001 • 23 citations

The serotonin antagonist mianserin for treatment of serotonin reuptake inhibitor-induced sexual dysfunction in women: an open-label add-on study.

2000 • 22 citations

The effects of a low tryptophan diet on brain 5 -HT metabolism and 5-HT-mediated neuroendocrine responses in the male rat

1995 • 19 citations

Regulation of serotonin 5-HT2C receptors by chronic ligand exposure

2004 • 19 citations

Effect of reserpine on behavioural responses to agonists at 5-HT1A, 5-HT1B, 5-HT2A, and 5-HT2C receptor subtypes

1999 • 18 citations

N-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline studies on the role of 5-HT1A and 5-HT2 receptors in mediating foot-shock-induced ultrasonic vocalisation in adult rats

1999 • 16 citations

Agomelatine

2003 • 15 citations

Long-term antidepressant treatment restores clonidine's effect on growth hormone secretion in a genetic animal model of depression

1996 • 13 citations

Melatonin in Depression

1987 • 13 citations

Serotonin Control of Dopaminergic Neurotransmission: Focus on 5-HT2 Receptors

2003 • 13 citations

ECT alters human monoamines in a different manner from that of antidepressant drugs.

1988 • 12 citations

Enhancement of Serotonin 2C Receptor mRNA Expression by Antidepressants Possessing the Receptor-Blocking Activity in the Rat Brain

1998 • 10 citations

An innovative method for rapid characterisation of phospholipase C activity: SB242,084 competitively antagonises 5-HT2C receptor-mediated [3H]phosphatidylinositol depletion

2000 • 8 citations